Research Output per year
Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
Neuroblastoma
Medicine & Life Sciences
Glioblastoma
Medicine & Life Sciences
Glioma
Medicine & Life Sciences
temozolomide
Medicine & Life Sciences
Cells
Chemical Compounds
Phenotype
Medicine & Life Sciences
Alendronate
Medicine & Life Sciences
Centrosome
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2011 2019
- 82 Citations
- 6 h-Index
- 8 Article
Altered function of the glutamate–aspartate transporter GLAST, a potential therapeutic target in glioblastoma
Corbetta, C., Di Ianni, N., Bruzzone, M. G., Patanè, M., Pollo, B., Cantini, G., Cominelli, M., Zucca, I., Pisati, F., Poliani, P. L., Finocchiaro, G. & Pellegatta, S., Jan 1 2019, (Accepted/In press) In : International Journal of Cancer.Research output: Contribution to journal › Article
Glioblastoma
Glutamic Acid
Glioma
Therapeutics
Apoptosis
5
Citations
(Scopus)
Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy
Pellegatta, S., Savoldo, B., Di Ianni, N., Corbetta, C., Chen, Y., Patané, M., Sun, C., Pollo, B., Ferrone, S., DiMeco, F., Finocchiaro, G. & Dotti, G., Feb 28 2018, In : Science Translational Medicine. 10, 430, eaao2731.Research output: Contribution to journal › Article
Antigen Receptors
Glioblastoma
Cell- and Tissue-Based Therapy
Tumor Necrosis Factor-alpha
Neoplasms
7
Citations
(Scopus)
The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma
Pessina, S., Cantini, G., Kapetis, D., Cazzato, E., Di Ianni, N., Finocchiaro, G. & Pellegatta, S., Apr 18 2016, (Accepted/In press) In : OncoImmunology.Research output: Contribution to journal › Article
temozolomide
Multiple Drug Resistance
Glioma
Natural Killer Cells
Drug Therapy
10
Citations
(Scopus)
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype
Ruggeri, P., Farina, A. R., Di Ianni, N., Cappabianca, L., Ragone, M., Ianni, G., Gulino, A. & Mackay, A. R., Apr 15 2014, In : PLoS One. 9, 4, e94568.Research output: Contribution to journal › Article
Mitochondria
Neoplastic Stem Cells
Oncogene Proteins
Stem cells
Neuroblastoma
8
Citations
(Scopus)
TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype
Farina, A. R., Di Ianni, N., Cappabianca, L., Ruggeri, P., Ragone, M., Ianni, G., Gulino, A. & Mackay, A. R., 2013, In : BioMed Research International. 2013, 740187.Research output: Contribution to journal › Article
Centrosome
Tubulin
Neuroblastoma
Microtubules
Nucleation